Jilin Province Huinan Changlong Bio-pharmacy Balance Sheet Health
Financial Health criteria checks 5/6
Jilin Province Huinan Changlong Bio-pharmacy has a total shareholder equity of CN¥1.6B and total debt of CN¥83.8M, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are CN¥2.4B and CN¥780.2M respectively. Jilin Province Huinan Changlong Bio-pharmacy's EBIT is CN¥181.3M making its interest coverage ratio -5.4. It has cash and short-term investments of CN¥645.7M.
Key information
5.3%
Debt to equity ratio
CN¥83.75m
Debt
| Interest coverage ratio | -5.4x |
| Cash | CN¥645.68m |
| Equity | CN¥1.58b |
| Total liabilities | CN¥780.16m |
| Total assets | CN¥2.36b |
Recent financial health updates
No updates
Recent updates
Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More
May 21
There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings
Apr 04With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case
Mar 26Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel
Dec 27With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case
Jul 12It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year
Jun 05How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?
Nov 26Financial Position Analysis
Short Term Liabilities: 8049's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥666.9M).
Long Term Liabilities: 8049's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥113.2M).
Debt to Equity History and Analysis
Debt Level: 8049 has more cash than its total debt.
Reducing Debt: 8049's debt to equity ratio has increased from 0.2% to 5.3% over the past 5 years.
Debt Coverage: 8049's debt is well covered by operating cash flow (377.3%).
Interest Coverage: 8049 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:34 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ssu-Han Fu | Jih Sun Securities Investment Consulting Co., Ltd. |